Published in AIDS on August 20, 2007
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (2008) 2.14
Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. J Infect Dis (2010) 1.11
Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review. PLoS One (2011) 0.97
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database. J Int AIDS Soc (2012) 0.90
Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy. BMC Infect Dis (2010) 0.90
Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists. Blood (2012) 0.88
Respiratory infection complicating HIV infection. Curr Opin Infect Dis (2008) 0.86
Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Med (2009) 0.85
Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV AIDS (Auckl) (2010) 0.82
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection (2013) 0.78
Human Immunodeficiency Virus (HIV) Quality Indicators Are Similar Across HIV Care Delivery Models. Open Forum Infect Dis (2017) 0.78
Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease. Eur J Med Res (2009) 0.77
T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences. Viral Immunol (2016) 0.75
Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients. J Int Assoc Provid AIDS Care (2016) 0.75
Withdrawal of Pneumocystis prophylaxis. AIDS (2008) 0.75
HIV infection with viro-immunological dissociation in a patient with polycystic kidney disease: Candidate for transplantation? IDCases (2016) 0.75
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med (2011) 4.68
The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med (2015) 2.85
Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA (2003) 2.73
Age of transfused blood in critically ill adults. N Engl J Med (2015) 2.52
Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials. Crit Care Med (2008) 2.33
Ultrasound-Guided Subclavian Vein Catheterization: A Systematic Review and Meta-Analysis. Crit Care Med (2015) 2.21
Can erythropoietin eradicate red cell transfusions in the critically ill? Crit Care Med (2006) 2.21
The future of clinical trials evaluating blood substitutes. JAMA (2008) 2.14
Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database Syst Rev (2014) 2.01
Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. BMJ (2009) 1.98
Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury. Neurocrit Care (2006) 1.87
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study. PLoS One (2009) 1.87
Revisiting transfusion practices in critically ill patients. Crit Care Med (2005) 1.78
Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med (2007) 1.75
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2011) 1.74
Determination of neurologic prognosis and clinical decision making in adult patients with severe traumatic brain injury: a survey of Canadian intensivists, neurosurgeons, and neurologists. Crit Care Med (2013) 1.72
Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study. CMAJ (2011) 1.72
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS (2005) 1.68
Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis (2005) 1.63
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review. Open Med (2009) 1.62
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2011) 1.53
Red blood cell transfusions in critically ill patients. JAMA (2002) 1.51
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia. AIDS (2011) 1.48
Red blood cell transfusion practices amongst Canadian anesthesiologists: a survey. Can J Anaesth (2006) 1.47
Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc (2011) 1.46
Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment. Eur J Gastroenterol Hepatol (2012) 1.43
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med (2011) 1.42
Sex, politics, and religion: why AIDS is a secular issue. J Int Assoc Physicians AIDS Care (Chic) (2004) 1.40
Twenty-five years of AIDS. CMAJ (2006) 1.39
Circulating endothelial progenitor cell levels are not reduced in HIV-infected men. J Infect Dis (2012) 1.39
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ (2007) 1.38
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm (Vienna) (2011) 1.35
Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS (2008) 1.35
Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2010) 1.35
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clin Pharmacol Ther (2004) 1.33
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis (2005) 1.32
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis (2002) 1.30
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ (2007) 1.29
Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2010) 1.26
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine (2004) 1.23
Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet (2010) 1.21
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr (2009) 1.19
Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection. J Infect Dis (2008) 1.17
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. AIDS (2011) 1.16
IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol (2007) 1.15
Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth (2011) 1.14
Expert opinion on laparoscopic surgery for colorectal cancer parallels evidence from a cumulative meta-analysis of randomized controlled trials. PLoS One (2012) 1.11
Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One (2013) 1.09
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis (2006) 1.07
Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data. Liver Int (2011) 1.06
Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. PLoS Pathog (2010) 1.05
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS (2002) 1.05
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg (2006) 1.03
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation (2010) 1.02
Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem (2006) 1.02
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. J Clin Pharmacol (2006) 1.02
Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Clin Dev Immunol (2012) 0.99
Development and validation of the HIV Medication Readiness Scale. Assessment (2007) 0.97
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS (2006) 0.97
Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review. PLoS One (2011) 0.97
The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage (2008) 0.97
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis. Clin Infect Dis (2012) 0.97
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev (2016) 0.96
IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol (2007) 0.96
Systematic review of the effectiveness of training programs in writing for scholarly publication, journal editing, and manuscript peer review (protocol). Syst Rev (2013) 0.95
Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician (2010) 0.95
Validation of diagnostic codes for intussusception and quantification of childhood intussusception incidence in Ontario, Canada: a population-based study. J Pediatr (2013) 0.94
Cardiovascular complications of Salmonella enteritidis infection. Can J Cardiol (2010) 0.94
Inflammation and repair in viral hepatitis C. Dig Dis Sci (2008) 0.94
Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment. Clin Epidemiol (2011) 0.93
Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J Immunol (2010) 0.93
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis. Clin Exp Gastroenterol (2012) 0.93
Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies. Crit Care (2012) 0.92
Impact of interventional bronchoscopy on quality of life in malignant airway obstruction. Respiration (2008) 0.92
Retracted Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells. J Biol Chem (2007) 0.91
Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173). AIDS Care (2010) 0.91
Do transfusions get to the heart of the matter? JAMA (2004) 0.91
Effect of epidural analgesia in patients with traumatic rib fractures: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth (2009) 0.90
IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection. J Leukoc Biol (2010) 0.90
Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale. Scand J Caring Sci (2009) 0.89
Bed utilization of patients with methicillin-resistant Staphylococcus aureus in a Canadian tertiary-care center. Infect Control Hosp Epidemiol (2002) 0.89
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus. Can J Gastroenterol (2008) 0.88
Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Transfusion (2005) 0.88
Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies. BMJ (2013) 0.88
Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment. Int J Tuberc Lung Dis (2011) 0.87
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins. J Pharm Pharm Sci (2011) 0.87
Fluid Resuscitation with 5% albumin versus Normal Saline in Early Septic Shock: a pilot randomized, controlled trial. J Crit Care (2011) 0.86